tiprankstipranks
Ausnutria Dairy Corp. Ltd. (HK:1717)
:1717
Hong Kong Market
Want to see HK:1717 full AI Analyst Report?

Ausnutria Dairy Corp. Ltd. (1717) AI Stock Analysis

4 Followers

Top Page

HK:1717

Ausnutria Dairy Corp. Ltd.

(1717)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - Gpt-5.6Sol)
Rating:52Neutral
Price Target:
HK$1.00
▼(-50.25% Downside)
Action:Reiterated
Date:07/15/26
The score is held back primarily by weakened profitability versus prior years and historically volatile cash flow (despite a 2025 revenue rebound). Technicals also remain bearish with the stock trading below all major moving averages and negative MACD. These negatives are partially offset by a relatively attractive valuation (P/E ~10.7) and a ~4.1% dividend yield.
Positive Factors
2025 Revenue Rebound
The strong 2025 revenue recovery indicates that Ausnutria can regain sales momentum after earlier declines. A return to growth supports scale across its branded nutrition portfolio and provides a stronger base for improving operating leverage, product investment, and distribution over the next several quarters.
Negative Factors
Margin Compression
The sustained decline in gross and net margins shows that the 2025 sales recovery has not restored historical earning power. Lower profitability may reflect weaker pricing power or higher cost intensity, limiting reinvestment capacity and making earnings more sensitive to modest operating setbacks.
Read all positive and negative factors
Positive Factors
Negative Factors
2025 Revenue Rebound
The strong 2025 revenue recovery indicates that Ausnutria can regain sales momentum after earlier declines. A return to growth supports scale across its branded nutrition portfolio and provides a stronger base for improving operating leverage, product investment, and distribution over the next several quarters.
Read all positive factors

Ausnutria Dairy Corp. Ltd. (1717) vs. iShares MSCI Hong Kong ETF (EWH)

Ausnutria Dairy Corp. Ltd. Business Overview & Revenue Model

Company Description
Ausnutria Dairy Corporation Ltd, an investment holding firm, is primarily involved in the entire lifecycle of infant formula and other dairy products, encompassing research and development, milk sourcing, processing, manufacturing, packaging, mark...
How the Company Makes Money
Ausnutria primarily makes money by selling branded nutrition products, with infant formula (including goat milk and cow milk-based formula) as a core revenue driver. Revenue is generated through (1) sales of infant formula products to distributors...

Ausnutria Dairy Corp. Ltd. Financial Statement Overview

Summary
2025 revenue rebounded strongly (+28.8% YoY), and leverage appears manageable (debt-to-equity ~0.43). However, profitability is structurally weaker than 2020–2021: gross margin has fallen to ~39% (from ~50%) and net margin is low (~2–3% in 2023–2025). Cash generation is also a key drag—free cash flow was deeply negative in 2022–2024 before turning modestly positive in 2025, indicating uneven cash conversion.
Income Statement
48
Neutral
Balance Sheet
62
Positive
Cash Flow
40
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.49B7.40B7.38B7.80B8.58B
Gross Profit2.89B3.11B2.85B3.39B4.15B
EBITDA439.20M645.26M503.39M529.50M1.26B
Net Income177.51M235.97M174.39M216.53M763.79M
Balance Sheet
Total Assets10.26B9.66B10.03B9.80B9.51B
Cash, Cash Equivalents and Short-Term Investments931.67M1.42B2.04B1.87B2.26B
Total Debt2.62B2.25B2.42B1.56B1.30B
Total Liabilities4.17B3.88B4.28B4.23B4.02B
Stockholders Equity6.03B5.72B5.69B5.65B5.54B
Cash Flow
Free Cash Flow153.73M-86.32M-459.31M-1.06B514.93M
Operating Cash Flow362.80M299.37M224.71M-357.54M1.07B
Investing Cash Flow-702.78M-899.16M-740.92M-723.98M-606.57M
Financing Cash Flow22.87M-273.59M682.45M664.11M-34.09M

Ausnutria Dairy Corp. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.01
Price Trends
50DMA
1.21
Negative
100DMA
1.31
Negative
200DMA
1.62
Negative
Market Momentum
MACD
-0.02
Negative
RSI
45.84
Neutral
STOCH
56.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1717, the sentiment is Negative. The current price of 2.01 is above the 20-day moving average (MA) of 1.18, above the 50-day MA of 1.21, and above the 200-day MA of 1.62, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 45.84 is Neutral, neither overbought nor oversold. The STOCH value of 56.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1717.

Ausnutria Dairy Corp. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
HK$6.51B24.879.30%2.70%-3.39%20.09%
63
Neutral
HK$23.32B11.067.29%8.37%-4.22%-30.99%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
HK$33.27B5.8525.72%3.81%5.80%-9.69%
60
Neutral
HK$11.16B13.3211.77%5.47%24.27%
57
Neutral
HK$70.93B32.294.53%3.30%3.48%
52
Neutral
HK$2.04B-2.89-11.03%4.33%-8.08%-376.61%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1717
Ausnutria Dairy Corp. Ltd.
1.16
-1.27
-52.31%
HK:0151
Want Want China Holdings
2.84
-2.91
-50.59%
HK:1112
Health and Happiness (H&H) International Holdings
17.91
4.00
28.76%
HK:2319
China Mengniu Dairy Co
18.12
3.43
23.32%
HK:0345
Vitasoy International Holdings
6.47
-2.03
-23.93%
HK:6186
China Feihe Limited
2.53
-1.38
-35.37%

Ausnutria Dairy Corp. Ltd. Corporate Events

Ausnutria Dairy Swings to Interim Loss as Revenue and Margins Slide
Aug 26, 2026
Ausnutria Dairy Corporation reported a sharp downturn for the six months ended 30 June 2026, with revenue falling 18.6% year-on-year to RMB3.16 billion and gross profit dropping 68.1%. The group’s gross margin compressed from 41.9% to 16.4%,...
Ausnutria Board Sets August Meeting to Review Interim Results and Dividend
Aug 10, 2026
Ausnutria Dairy Corporation Ltd. has scheduled a board meeting for 26 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider whether to recommend the payment of an interim dividend...
Ausnutria Dairy Flags H1 Loss on One-Off Charges but Stresses Stable Core Business
Jul 24, 2026
Ausnutria Dairy warned that revenue for the first half of 2026 is expected to fall to about RMB3.07 billion–3.17 billion from RMB3.89 billion a year earlier, with the group swinging to a net loss of RMB685 million–785 million versus a ...
Ausnutria Sells 35% of Amalthea to A-ware and Locks In 10-Year Supply Deal
Jul 14, 2026
Ausnutria Dairy Corporation’s subsidiary Ausnutria B.V. has agreed to sell a 35% equity stake in its indirect wholly owned subsidiary Amalthea to Dutch group A-ware for about EUR15.8 million, alongside assigning a shareholder loan of EUR1.4 ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 15, 2026